268 related articles for article (PubMed ID: 22795517)
1. Mapping of pelvic lymph node metastases in prostate cancer.
Joniau S; Van den Bergh L; Lerut E; Deroose CM; Haustermans K; Oyen R; Budiharto T; Ameye F; Bogaerts K; Van Poppel H
Eur Urol; 2013 Mar; 63(3):450-8. PubMed ID: 22795517
[TBL] [Abstract][Full Text] [Related]
2. Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement.
Van den Bergh L; Joniau S; Haustermans K; Deroose CM; Isebaert S; Oyen R; Mottaghy FM; Ameye F; Berkers J; Van Poppel H; Lerut E
Acta Oncol; 2015 Jun; 54(6):896-902. PubMed ID: 25591936
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic drainage in prostate carcinoma assessed by lymphoscintigraphy and SPECT/CT: its importance for the sentinel node procedure.
de Bonilla-Damiá A; Roberto Brouwer O; Meinhardt W; Valdés-Olmos RA
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):66-70. PubMed ID: 22055110
[TBL] [Abstract][Full Text] [Related]
4. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles.
Winter A; Kowald T; Paulo TS; Goos P; Engels S; Gerullis H; Schiffmann J; Chavan A; Wawroschek F
Int J Nanomedicine; 2018; 13():6689-6698. PubMed ID: 30425483
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer.
KleinJan GH; van den Berg NS; Brouwer OR; de Jong J; Acar C; Wit EM; Vegt E; van der Noort V; Valdés Olmos RA; van Leeuwen FW; van der Poel HG
Eur Urol; 2014 Dec; 66(6):991-8. PubMed ID: 25092539
[TBL] [Abstract][Full Text] [Related]
7. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
[TBL] [Abstract][Full Text] [Related]
9. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients.
Buckle T; Brouwer OR; Valdés Olmos RA; van der Poel HG; van Leeuwen FW
J Nucl Med; 2012 Jul; 53(7):1026-33. PubMed ID: 22645296
[TBL] [Abstract][Full Text] [Related]
10. Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.
KleinJan GH; van den Berg NS; de Jong J; Wit EM; Thygessen H; Vegt E; van der Poel HG; van Leeuwen FW
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1278-87. PubMed ID: 26768422
[TBL] [Abstract][Full Text] [Related]
11. Radioisotopic detection of sentinel lymph nodes in clinically localized high-risk prostate cancer.
Hinev A; Klissarova A; Ghenev P; Kolev N; Chaushev B; Chankov P; Anakievski D; Dyakov S; Stratev S; Deliisky T
J BUON; 2009; 14(4):661-7. PubMed ID: 20148459
[TBL] [Abstract][Full Text] [Related]
12. A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
Wit EMK; KleinJan GH; Berrens AC; van Vliet R; van Leeuwen PJ; Buckle T; Donswijk ML; Bekers EM; van Leeuwen FWB; van der Poel HG
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2861-2871. PubMed ID: 37036490
[TBL] [Abstract][Full Text] [Related]
13. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
[TBL] [Abstract][Full Text] [Related]
14. Anatomical localization of radiocolloid tracer deposition affects outcome of sentinel node procedures in prostate cancer.
de Korne CM; Wit EM; de Jong J; Valdés Olmos RA; Buckle T; van Leeuwen FWB; van der Poel HG
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2558-2568. PubMed ID: 31377820
[TBL] [Abstract][Full Text] [Related]
15. Value and efficiency of sentinel lymph node diagnostics in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal, minimally invasive approach.
Lützen U; Zuhayra M; Marx M; Zhao Y; Colberg C; Knüpfer S; Baumann R; Kähler KC; Jünemann KP; Naumann CM
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2313-2323. PubMed ID: 27519598
[TBL] [Abstract][Full Text] [Related]
16. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.
Mattei A; Fuechsel FG; Bhatta Dhar N; Warncke SH; Thalmann GN; Krause T; Studer UE
Eur Urol; 2008 Jan; 53(1):118-25. PubMed ID: 17709171
[TBL] [Abstract][Full Text] [Related]
17. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer.
Hubalewska A; Sowa-Staszczak A; Huszno B; Markocka A; Pityński K; Basta A; Opławski M; Basta P
Nucl Med Rev Cent East Eur; 2003; 6(2):127-30. PubMed ID: 14737727
[TBL] [Abstract][Full Text] [Related]
18. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging.
Warncke SH; Mattei A; Fuechsel FG; Z'Brun S; Krause T; Studer UE
Eur Urol; 2007 Jul; 52(1):126-32. PubMed ID: 17258385
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic sentinel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinoma: a prospective study of 200 patients.
Rousseau C; Rousseau T; Campion L; Lacoste J; Aillet G; Potiron E; Lacombe M; Le Coguic G; Mathieu C; Kraeber-Bodéré F
J Nucl Med; 2014 May; 55(5):753-8. PubMed ID: 24686781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
